CONMED Cash Flow from Investing Activities 2010-2025 | CNMD
CONMED cash flow from investing activities from 2010 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
CONMED Annual Cash Flow Investing
(Millions of US $) |
| 2024 |
$-13 |
| 2023 |
$-20 |
| 2022 |
$-250 |
| 2021 |
$-15 |
| 2020 |
$-14 |
| 2019 |
$-388 |
| 2018 |
$-17 |
| 2017 |
$-29 |
| 2016 |
$-266 |
| 2015 |
$-24 |
| 2014 |
$-21 |
| 2013 |
$-18 |
| 2012 |
$-106 |
| 2011 |
$-22 |
| 2010 |
$-20 |
| 2009 |
$-22 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.851B |
$1.307B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
